BARCHIESI, GIACOMO
 Distribuzione geografica
Continente #
NA - Nord America 486
EU - Europa 232
AS - Asia 48
AF - Africa 2
SA - Sud America 1
Totale 769
Nazione #
US - Stati Uniti d'America 482
IT - Italia 107
SE - Svezia 59
IN - India 26
DE - Germania 18
GB - Regno Unito 17
CN - Cina 12
FI - Finlandia 12
SG - Singapore 5
CA - Canada 4
FR - Francia 4
BG - Bulgaria 3
IR - Iran 3
RO - Romania 3
UA - Ucraina 3
CH - Svizzera 2
EE - Estonia 2
HK - Hong Kong 2
IE - Irlanda 2
TG - Togo 2
AR - Argentina 1
Totale 769
Città #
Fairfield 87
Woodbridge 49
Seattle 43
Ashburn 36
Houston 32
Rome 31
Chandler 27
Cambridge 25
Ann Arbor 23
Wilmington 21
San Paolo di Civitate 14
Dearborn 13
Milan 11
Princeton 11
Helsinki 9
Lawrence 8
New York 8
Beijing 7
Cappelle sul Tavo 7
Millbury 7
Surrey 7
Bremen 6
Boston 5
Plano 5
Sacramento 5
San Diego 4
Glasgow 3
Sofia 3
Vicenza 3
Andover 2
Bari 2
Dublin 2
Fano 2
Ferrara 2
Florence 2
Hong Kong 2
Kunming 2
Levallois-perret 2
Lomé 2
Norwalk 2
Ottawa 2
Sinalunga 2
Tallinn 2
Torino 2
Toronto 2
Augusta 1
Barletta 1
Bern 1
Birmingham 1
Bracciano 1
Caserta 1
Chieti 1
Edinburgh 1
Falkenstein 1
Falls Church 1
Federal 1
Forlì 1
Fremont 1
Guidonia 1
Hefei 1
Jacksonville 1
Kish 1
Liverpool 1
Marseille 1
Miami 1
Nanjing 1
Palermo 1
Phoenix 1
Portici 1
Pune 1
San Giuliano Milanese 1
Schio 1
Shenyang 1
Shimla 1
Singapore 1
Tehran 1
Vigonza 1
Totale 574
Nome #
Triple peptide vaccination as consolidation treatment in women affected by ovarian and breast cancer: clinical and immunological data of a phase I/II clinical trial 107
A multicenter REtrospective observational study of first-line treatment with PERtuzumab, trastuzumab and taxanes for advanced HER2 positive breast cancer patients. RePer Study 103
Distinct HR expression patterns significantly affect the clinical behavior of metastatic HER2+ breast cancer and degree of benefit from novel anti-HER2 agents in the real world setting 93
Long-Term Safety and Real-World Effectiveness of Trastuzumab in Breast Cancer 86
Prolactin as a potential negative predictive factor in metastatic non-small cell lung cancers (NSCLC) patients in treatment with Nivolumab (NIVO) 81
Preliminary results of a triple peptide escalating dose vaccination phase I/II clinical trial as consolidation treatment in women affected by ovarian cancer 74
Impact of BMI on HER2+ metastatic breast cancer patients treated with pertuzumab and/or trastuzumab emtansine. Real-world evidence 56
Immunotherapy in HER2-positive breast cancer. state of the art and future perspectives 52
Capecitabine and Temozolomide (CAPTEM) in advanced neuroendocrine neoplasms (NENs): a systematic review and pooled analysis 51
null 49
Observational multicenter study on the prognostic relevance of coagulation activation in risk assessment and stratification in locally advanced breast cancer. Outline of the arias trial 32
PANHER study: a 20-year treatment outcome analysis from a multicentre observational study of HER2-positive advanced breast cancer patients from the real-world setting 32
Neoadjuvant endocrine therapy in breast cancer. Current knowledge and future perspectives 17
Prolactin as a Potential Early Predictive Factor in Metastatic Non-Small Cell Lung Cancer Patients Treated with Nivolumab 9
Sarcopenia in Breast Cancer Patients: A Systematic Review and Meta-Analysis 8
The role of CXCL12 axis in pancreatic cancer: New biomarkers and potential targets 4
Totale 854
Categoria #
all - tutte 2.189
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 2.189


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201948 0 0 0 0 0 0 0 0 0 9 19 20
2019/2020221 11 4 7 6 27 30 29 33 27 30 10 7
2020/202197 16 7 8 8 3 2 1 3 5 38 6 0
2021/2022136 0 3 4 6 22 8 1 12 7 5 40 28
2022/2023183 30 45 17 15 18 11 6 12 19 1 8 1
2023/2024114 4 21 1 8 12 28 5 24 5 6 0 0
Totale 854